Yauheniya Baranchykava: Changing Lives Through Innovation in Hemophilia Care
Yauheniya Baranchykava, Hemofilia Squad Lead at Roche, shared a post on LinkedIn:
“Change the lives of people with hemophilia. That is our purpose.
This week we had the privilege of being part of the LATAM Hemophilia Meeting, along with medical specialists from all over Latin America committed to bringing the best science to their patients.
A meeting where knowledge is shared, experiences multiply and the objective is always the same: how do we get more people to access care that really transforms their lives?
Team Chile is committed to bringing science to our medical community.
Because we are convinced: the best science must reach our doctors and, through them, our patients.
Innovation in hemophilia goes far beyond reducing bleeding.
We are talking about children who can go to school without fear, adults who work, families who breathe easier.
Roche Chile’s commitment to hemophilia is real, it is continuous and it is growing.
Thanks to LATAM team, Carolina Ocampo, Josue Hidalgo G Andrea, Morales Heerlein, and their teams to make it possible and team Peru to receive us.
It was amazing!”

Stay updated with Hemostasis Today.
-
Aug 13, 2026, 18:39Lukas Röthlisberger: Real-World Evidence on Effectiveness and Safety of Rivaroxaban in Children
-
Aug 13, 2026, 18:36Soner Yilmaz: Blood Safety in Türkiye Through More Than 22.5 Million Blood Donations
-
Aug 13, 2026, 18:31Muthukumarasamy Raja: FDA Approval of EZPLAZ Marks a Breakthrough in Emergency Plasma Care
-
Aug 13, 2026, 18:29Peter Zdziarski: Protecting Our Community While Creating a Future Where We Are No Longer Needed
-
Aug 13, 2026, 18:29Morgan E Amos: Thrilled to Receive the Student Research Award From HTRS
-
Aug 13, 2026, 16:38Sheharyar Raza: Plasma Exchange in Multiple Sclerosis
-
Aug 13, 2026, 16:31Juan Manuel Cisneros Carrasco: The True Cost of Blood Donation
-
Aug 13, 2026, 16:25Connie Montgomery: Bridging the Gap Between Patients, Culture and Clinical Trials
-
Aug 13, 2026, 16:16Isabella Presch: A New AI Approach to Protein Engineering